Fig. 9From: Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinomaGraphical abstract for the proposed mechanism of action of PH in HCCBack to article page